SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001213900-17-000258
Filing Date
2017-01-11
Accepted
2017-01-11 17:28:30
Documents
6

Document Format Files

Seq Description Document Type Size
1 REGISTRATION STATEMENT fs32017_oramedpharma.htm S-3 249172
2 OPINION OF ZYSMAN, AHARONI, GAYER AND SULLIVAN & WORCESTER LLP. fs32017ex5i_oramedpharma.htm EX-5.1 14470
3 CONSENT OF KESSELMAN & KESSELMAN, INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM. fs32017ex23i_oramedpharma.htm EX-23.1 5035
4 GRAPHIC image_001.jpg GRAPHIC 3826
5 GRAPHIC image_002.jpg GRAPHIC 5803
6 GRAPHIC image_003.jpg GRAPHIC 2603
  Complete submission text file 0001213900-17-000258.txt   287167
Mailing Address HI-TECH PARK 2/4 GIVAT-RAM PO BOX 39098 JERUSALEM L3 91390
Business Address HI-TECH PARK 2/4 GIVAT-RAM PO BOX 39098 JERUSALEM L3 91390 011 972-2-566-0001
ORAMED PHARMACEUTICALS INC. (Filer) CIK: 0001176309 (see all company filings)

IRS No.: 980376008 | State of Incorp.: DE | Fiscal Year End: 0831
Type: S-3 | Act: 33 | File No.: 333-215525 | Film No.: 17523584
SIC: 2834 Pharmaceutical Preparations